-+ 0.00%
-+ 0.00%
-+ 0.00%

Aikobio’s AK0406 flu prevention drug wins China IND clearance for clinical trials

PUBT·08/18/2026 09:26:51
Listen to the news
Aikobio’s AK0406 flu prevention drug wins China IND clearance for clinical trials
  • Shanghai Free Trade Zone Equity Investment Fund portfolio company Akesobio secured NMPA IND clearance for AK0406, a long-acting influenza prophylaxis injection.
  • The program entered clinical-stage development, described as China’s first influenza AFC (antiviral drug–Fc conjugate) candidate to reach trials.
  • Silicon wafer maker Zhongxin Wafer pulled its first 12-inch heavily doped <111> crystal ingots, expanding domestic supply options for low-resistivity substrates.
  • HPMicro launched ECAN-Lite, a communication gateway linking EtherCAT networks with CAN FD buses for industrial automation deployments.
  • Steering systems supplier LeeKr’s intelligent steering platform passed Automotive SPICE PAM V4.0 Capability Level 2, supporting global program delivery.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Free Trade Zone Equity Investment Fund Management Co Ltd published the original content used to generate this news brief on August 18, 2026, and is solely responsible for the information contained therein.